[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:paraganglioma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":93,"states":98},"Paraganglioma",13,11,[8,16,22,29,35,41,47,54,61,68,74,80,87],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07282587","Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma",[12],"Phase 2","RECRUITING","2026-08-26T02:17:42.501124Z","2026-05-05T02:43:29.477296Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT03206060","Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma\u002F Paraganglioma",[12],"2026-08-26T02:17:45.190188Z","2026-05-05T02:43:27.070855Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT06427798","Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma\u002FParaganglioma Previously Treated With Systemic Targeted Radioligand Therapy",[26],"Phase 1\u002FPhase 2","2026-08-26T02:18:45.196599Z","2026-07-05T05:32:16.752853Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT00107289","Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma",[12],"2026-08-26T02:15:02.712396Z","2026-05-05T02:43:27.512726Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT05636618","Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors",[26],"2026-08-26T02:17:03.534765Z","2026-07-05T05:32:16.808808Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT04924075","Belzutifan\u002FMK-6482 for the Treatment of Advanced Pheochromocytoma\u002FParaganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)",[12],"2026-08-26T02:17:01.714035Z","2026-07-05T05:32:16.796442Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":52,"content_modified":53},"NCT05636540","In Vivo PARP-1 Expression With 18F-FluorThanatrace PET\u002FCT in Patients With Pheochromocytoma and Paraganglioma",[51],"Early Phase 1","2026-08-26T02:19:27.519777Z","2026-05-05T02:43:27.634654Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":59,"content_modified":60},"NCT00004847","Diagnosis of Pheochromocytoma",[58],"Phase 1","2026-08-26T02:19:25.538428Z","2026-05-05T02:35:31.648966Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":66,"content_modified":67},"NCT04081701","68-Ga DOTATATE PET\u002FMRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.",[65],"Phase 4","2026-08-26T02:15:09.079045Z","2026-05-05T02:43:27.179150Z",{"nct_id":69,"title":70,"phases":71,"status":13,"updated_at":72,"content_modified":73},"NCT03160274","Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions",[],"2026-08-26T02:17:29.353236Z","2026-05-13T02:55:06.109199Z",{"nct_id":75,"title":76,"phases":77,"status":13,"updated_at":78,"content_modified":79},"NCT06377033","Using the EHR to Advance Genomic Medicine Across a Diverse Health System",[],"2026-08-26T02:15:48.613507Z","2026-05-05T02:43:26.987720Z",{"nct_id":81,"title":82,"phases":83,"status":84,"updated_at":85,"content_modified":86},"NCT07661420","211At-MABG in Adults With Advanced Neuroendocrine Cancers",[58],"NOT_YET_RECRUITING","2026-08-26T02:16:57.705506Z","2026-07-05T03:45:20.260334Z",{"nct_id":88,"title":89,"phases":90,"status":84,"updated_at":91,"content_modified":92},"NCT07714551","Zanzalintinib in Unresectable and Progressive MPGGs",[12],"2026-08-26T02:18:06.247899Z","2026-07-24T01:27:14.916149Z",[94],{"biomarker":95,"count":96,"slug":97},"Somatostatin Receptor",3,"somatostatin-receptor",[99,103,106,110,113],{"state":100,"count":101,"slug":102},"Maryland",5,"maryland",{"state":104,"count":101,"slug":105},"Pennsylvania","pennsylvania",{"state":107,"count":108,"slug":109},"New York",4,"new-york",{"state":111,"count":96,"slug":112},"Michigan","michigan",{"state":114,"count":96,"slug":115},"Missouri","missouri"]